Corvus Pharmaceuticals (CRVS) Stock Chart & Stock Price History $5.01 +0.28 (+5.92%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Corvus Pharmaceuticals Stock Price Performance 5 Day Performance-3.65%1 Month Performance+6.60%3 Month Performance-30.51%6 Month Performance+134.11%Year-To-Date Performance-6.36%1 Year Performance+151.76% Receive CRVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CRVS Stock Chart for Saturday, January, 18, 2025 CRVS Chart by TradingView Corvus Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/17/2025$4.73$5.01+5.92%$5.12$4.66719,048 shs$321.94 million01/16/2025$4.92$4.73-3.86%$4.92$4.60863,512 shs$303.95 million01/15/2025$5.10$4.92-3.53%$5.30$4.88650,653 shs$316.16 million01/14/2025$5.20$5.10-1.92%$5.32$5.00629,439 shs$327.71 million01/13/2025$5.33$5.20-2.44%$5.33$5.09604,089 shs$334.14 million01/10/2025$5.65$5.33-5.66%$5.58$5.26525,125 shs$342.49 million01/09/2025$5.65$5.65$5.89$5.53388,883 shs$363.05 million01/08/2025$5.75$5.65-1.74%$5.89$5.53388,883 shs$363.05 million01/07/2025$6.03$5.75-4.64%$6.14$5.75562,523 shs$369.48 million01/06/2025$5.83$6.03+3.43%$6.47$5.83821,176 shs$387.47 million Get the Latest News and Ratings for CRVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/03/2025$5.43$5.83+7.37%$5.93$5.38802,498 shs$374.62 million01/02/2025$5.35$5.43+1.50%$5.68$5.25909,045 shs$348.92 million01/01/2025$5.35$5.35$5.36$4.99785,717 shs$343.78 million12/31/2024$5.25$5.35+1.90%$5.36$4.99785,717 shs$343.78 million12/30/2024$5.21$5.25+0.77%$5.28$4.93752,036 shs$337.35 million12/27/2024$5.29$5.21-1.51%$5.43$5.10942,863 shs$334.78 million12/26/2024$4.90$5.29+7.96%$5.40$4.841.21 million shs$339.92 million12/25/2024$4.90$4.90$4.94$4.55658,069 shs$314.86 million12/24/2024$4.55$4.90+7.69%$4.94$4.55658,069 shs$314.86 million12/23/2024$4.99$4.55-8.82%$4.95$4.521.29 million shs$292.37 million12/20/2024$5.09$4.99-1.96%$5.34$4.732.59 million shs$320.64 million12/19/2024$4.70$5.09+8.30%$5.10$4.302.41 million shs$327.07 million12/18/2024$7.39$4.70-36.40%$5.20$3.7714.07 million shs$302.01 million12/17/2024$6.90$7.39+7.10%$7.44$6.441.15 million shs$474.86 million Related Companies Kiniksa Pharmaceuticals Stock Price Chart Maravai LifeSciences Stock Price Chart Arcus Biosciences Stock Price Chart Ocular Therapeutix Stock Price Chart Arvinas Stock Price Chart Calliditas Therapeutics AB (publ) Stock Price Chart Praxis Precision Medicines Stock Price Chart Day One Biopharmaceuticals Stock Price Chart ANI Pharmaceuticals Stock Price Chart Aurinia Pharmaceuticals Stock Price Chart Receive CRVS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRVS) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corvus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRVS Stock Alerts